Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899158 · ClinicalTrials.gov registry record
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 44
- Enrollment target
NCT00899158: Completed study, sponsored by Case Comprehensive Cancer Center.
NCT00899158 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899158 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
RATIONALE: Learning about biological markers in patients with pancreatic cancer and cachexia may help doctors predict patient outcome and may help the study of cancer in the future. PURPOSE: This laboratory study is examining biological markers in patients with pancreatic cancer experiencing weight loss.
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE biopsy
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-12 |
What the finished NCT00899158 record still lists
NCT00899158 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00899158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899158 about?
NCT00899158 is a clinical study titled "Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss". RATIONALE: Learning about biological markers in patients with pancreatic cancer and cachexia may help doctors predict patient outcome and may help the study of cancer in the future. PURPOSE: This laboratory study is examining biological markers in patients with pancreatic cancer experiencing weight...
What is the current status of trial NCT00899158?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2005-06. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00899158?
The interventions under investigation include: laboratory biomarker analysis (OTHER), biopsy (PROCEDURE), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00899158?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia